JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1997; 30:739-745
© 1997 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tkacova, R
Right arrow Articles by Bradley, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tkacova, R
Right arrow Articles by Bradley, T.

Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure

R Tkacova, PP Liu, MT Naughton, and TD Bradley

Queen Elizabeth Hospital Sleep Research Laboratory, Toronto Hospital, Ontario, Canada.

OBJECTIVES: We sought to determine the effects of continuous positive airway pressure (CPAP) on mitral regurgitant fraction (MRF) and plasma atrial natriuretic peptide (ANP) concentration in patients with congestive heart failure (CHF). BACKGROUND: In patients with CHF, elevated plasma ANP concentration is associated with elevated cardiac filling pressures. Secondary mitral regurgitation may contribute to elevation in plasma ANP concentration in patients with CHF. Because CPAP reduces transmural cardiac pressures and left ventricular (LV) volume, we hypothesized that long-term CPAP application would decrease the MRF and plasma ANP concentration in patients with CHF and Cheyne-Stokes respiration with central sleep apnea (CSR-CSA). METHODS: Seventeen patients with CHF and CSR-CSA underwent baseline assessments of plasma ANP concentration and left ventricular ejection fraction (LVEF) and MRF by radionuclide angiography. They were then randomized to receive nocturnal CPAP plus optimal medical therapy (n = 9) or optimal medical therapy alone (n = 8) for 3 months and were then reassessed. RESULTS: In the CPAP-treated group, LVEF increased from (mean +/-SEM) 20.2 +/- 4.2% to 28.2 +/- 5.3% (p < 0.02); MRF decreased from 32.8 +/- 7.7% to 19.4 +/- 5.5% (p < 0.02); and plasma ANP concentration decreased from 140.9 +/- 20.8 to 103.9 +/- 17.0 pg/ml (p < 0.05). The control group experienced no significant changes in LVEF, MRF or plasma ANP concentration. Among all patients, the change in plasma ANP concentration from baseline to 3 months correlated significantly with the change in MRF (r = 0.789, p < 0.0002). CONCLUSIONS: In patients with CHF, CPAP-induced reductions in MRF and plasma ANP concentration in association with improvements in LVEF indicate improved cardiac mechanics. Our findings also suggest that reductions in plasma ANP concentration were at least partly due to reductions in MRF.


This article has been cited by other articles:


Home page
CirculationHome page
V. K. Somers, D. P. White, R. Amin, W. T. Abraham, F. Costa, A. Culebras, S. Daniels, J. S. Floras, C. E. Hunt, L. J. Olson, et al.
Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)
Circulation, September 2, 2008; 118(10): 1080 - 1111.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. K. Somers, D. P. White, R. Amin, W. T. Abraham, F. Costa, A. Culebras, S. Daniels, J. S. Floras, C. E. Hunt, L. J. Olson, et al.
Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)
J. Am. Coll. Cardiol., August 19, 2008; 52(8): 686 - 717.
[Full Text] [PDF]


Home page
ChestHome page
T. Kara, M. Novak, J. Nykodym, K. A. Bybee, J. Meluzin, M. Orban, Z. Novakova, J. Lipoldova, D. L. Hayes, M. Soucek, et al.
Short-term Effects of Cardiac Resynchronization Therapy on Sleep-Disordered Breathing in Patients With Systolic Heart Failure
Chest, July 1, 2008; 134(1): 87 - 93.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Garcia-Touchard, V. K. Somers, L. J. Olson, and S. M. Caples
Central Sleep Apnea: Implications for Congestive Heart Failure
Chest, June 1, 2008; 133(6): 1495 - 1504.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Arzt, J. S. Floras, A. G. Logan, R. J. Kimoff, F. Series, D. Morrison, K. Ferguson, I. Belenkie, M. Pfeifer, J. Fleetham, et al.
Suppression of Central Sleep Apnea by Continuous Positive Airway Pressure and Transplant-Free Survival in Heart Failure: A Post Hoc Analysis of the Canadian Continuous Positive Airway Pressure for Patients With Central Sleep Apnea and Heart Failure Trial (CANPAP)
Circulation, June 26, 2007; 115(25): 3173 - 3180.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. D. Sin, E. Wong, I. Mayers, D. C. Lien, D. Feeny, H. Cheung, W. Q. Gan, and S. F. P. Man
Effects of Nocturnal Noninvasive Mechanical Ventilation on Heart Rate Variability of Patients With Advanced COPD
Chest, January 1, 2007; 131(1): 156 - 163.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
V. L. Wittmer, G. M. S. Simoes, L. C. M. Sogame, and E. C. Vasquez
Effects of continuous positive airway pressure on pulmonary function and exercise tolerance in patients with congestive heart failure.
Chest, July 1, 2006; 130(1): 157 - 163.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Arzt and T. D. Bradley
Treatment of Sleep Apnea in Heart Failure
Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1300 - 1308.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C Philippe, M Stoica-Herman, X Drouot, B Raffestin, P Escourrou, L Hittinger, P-L Michel, S Rouault, and M-P d'Ortho
Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period
Heart, March 1, 2006; 92(3): 337 - 342.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. D. Bradley, A. G. Logan, R. J. Kimoff, F. Series, D. Morrison, K. Ferguson, I. Belenkie, M. Pfeifer, J. Fleetham, P. Hanly, et al.
Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure.
N. Engl. J. Med., November 10, 2005; 353(19): 2025 - 2033.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Ancoli-Israel, E. R. DuHamel, C. Stepnowsky, R. Engler, M. Cohen-Zion, and M. Marler
The Relationship Between Congestive Heart Failure, Sleep Apnea, and Mortality in Older Men
Chest, October 1, 2003; 124(4): 1400 - 1405.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Tulaimat, B. Mokhlesi, D. Stevens, M. D. Weinstein, T. D. Bradley, J. S. Floras, and K. Usui
Continuous Positive Airway Pressure in Patients with Heart Failure
N. Engl. J. Med., July 3, 2003; 349(1): 93 - 95.
[Full Text] [PDF]


Home page
CirculationHome page
T. D. Bradley and J. S. Floras
Sleep Apnea and Heart Failure: Part II: Central Sleep Apnea
Circulation, April 8, 2003; 107(13): 1822 - 1826.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Nakayama, C. A. Smith, J. R. Rodman, J. B. Skatrud, and J. A. Dempsey
Effect of Ventilatory Drive on Carbon Dioxide Sensitivity below Eupnea during Sleep
Am. J. Respir. Crit. Care Med., May 1, 2002; 165(9): 1251 - 1260.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. S. T. LEUNG and T. DOUGLAS BRADLEY
Sleep Apnea and Cardiovascular Disease
Am. J. Respir. Crit. Care Med., December 15, 2001; 164(12): 2147 - 2165.
[Full Text] [PDF]


Home page
ChestHome page
A. T. Yan, T. D. Bradley, and P. P. Liu
The Role of Continuous Positive Airway Pressure in the Treatment of Congestive Heart Failure
Chest, November 1, 2001; 120(5): 1675 - 1685.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. D. Sin, A. G. Logan, F. S. Fitzgerald, P. P. Liu, and T. D. Bradley
Effects of Continuous Positive Airway Pressure on Cardiovascular Outcomes in Heart Failure Patients With and Without Cheyne-Stokes Respiration
Circulation, July 4, 2000; 102(1): 61 - 66.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. MEHTA, P. P. LIU, F. S. FITZGERALD, Y. K. ALLIDINA, and T. DOUGLAS BRADLEY
Effects of Continuous Positive Airway Pressure on Cardiac Volumes in Patients with Ischemic and Dilated Cardiomyopathy
Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 128 - 134.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. D. SIN, F. FITZGERALD, J. D. PARKER, G. NEWTON, J. S. FLORAS, and T. D. BRADLEY
Risk Factors for Central and Obstructive Sleep Apnea in 450 Men And Women with Congestive Heart Failure
Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1101 - 1106.
[Abstract] [Full Text]


Home page
ThoraxHome page
M T Naughton
Pathophysiology and treatment of Cheyne-Stokes respiration
Thorax, June 1, 1998; 53(6): 514 - 518.
[Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1997 by the American College of Cardiology Foundation.